🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition The Pill That Promised a Revolution: Why Eli Lilly's Foundayo Is Launching Slower Than Wall Street Expected Speed Over Scrutiny? The High-Stakes Gamble Behind the NHS's New Fast-Track Drug Pilots A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 08 Jul 2026 · ClinicalTrials.gov

Clinical Trials in Texas

← All US trials

The most recently updated industry-sponsored clinical trials recruiting across the United States — searchable by condition, sponsor, phase and state. Refreshed daily from the ClinicalTrials.gov registry.

25
Recruiting now
35
Studies tracked
Texas
Selected state
Recruiting Phase 3
Diabetes Mellitus, Type 1
Eli Lilly and Company · started 2026-02-05
📍 Colorado · Florida · Pennsylvania · Texas · Virginia
NCT07222332 on ClinicalTrials.gov ↗
Recruiting Phase 3
Phelan-McDermid Syndrome
Neuren Pharmaceuticals Limited · started 2025-11-12
📍 California · Illinois · Maryland · Massachusetts · New York · Ohio · Texas
NCT07281079 on ClinicalTrials.gov ↗
Recruiting
Acute Respiratory Infections (ARIs)
Lumos Diagnostics · started 2025-10-09
📍 California · Florida · Ohio · Pennsylvania · South Carolina · Texas
NCT07211997 on ClinicalTrials.gov ↗
Recruiting Phase 1
Lymphoma, B-Cell
Bantam Pharmaceuticals · started 2025-02-14
📍 North Carolina · Texas
NCT06792734 on ClinicalTrials.gov ↗
Recruiting Phase 3
Alzheimer Disease
Eli Lilly and Company · started 2025-08-25
📍 Texas
NCT07142954 on ClinicalTrials.gov ↗
Active Phase 1
Advanced Solid Tumor, Metastatic Colorectal Carcinoma, Head and Neck Squamous Cell Carcinoma, Non-small Cell Lung Cancer
AstraZeneca · started 2024-07-31
📍 California · Illinois · Nebraska · Ohio · Texas · Washington
NCT06147037 on ClinicalTrials.gov ↗
Recruiting
Coronary Artery Disease
Teleflex · started 2025-07-18
📍 California · Kansas · Massachusetts · Missouri · New York · Texas · West Virginia
NCT06779630 on ClinicalTrials.gov ↗
Recruiting Phase 1
Advanced Solid Tumors, Breast Cancer Recurrent, Ovarian Cancer, High-grade Serous Ovarian Carcinoma
Accent Therapeutics · started 2025-03-21
📍 Florida · Michigan · Tennessee · Texas · Virginia
NCT06799065 on ClinicalTrials.gov ↗
Active Phase 1/Phase 2
Diffuse Large B-Cell Lymphoma, Follicular Lymphoma
Genmab · started 2020-11-03
📍 Alabama · California · Massachusetts · Michigan · New Jersey · New York · North Carolina · Texas
NCT04663347 on ClinicalTrials.gov ↗
Recruiting
Crohn Disease, Colitis, Ulcerative
Janssen Scientific Affairs, LLC · started 2021-06-24
📍 Texas
NCT04372108 on ClinicalTrials.gov ↗
Recruiting Phase 3
Obesity, Weight Gain
Eli Lilly and Company · started 2024-06-03
📍 California · Delaware · Idaho · Illinois · Indiana · New York · Texas · Utah
NCT06439277 on ClinicalTrials.gov ↗
Recruiting
Dysfunction of Eustachian Tube
Integra LifeSciences Corporation · started 2025-06-17
📍 California · Massachusetts · Michigan · Minnesota · Ohio · Pennsylvania · Texas · Utah
NCT07071298 on ClinicalTrials.gov ↗
Active Phase 1
HIV Infections
ViiV Healthcare · started 2025-07-10
📍 California · Florida · Illinois · Missouri · New York · Ohio · Pennsylvania · Texas
NCT07053384 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Multiple Myeloma
AbbVie · started 2025-07-23
📍 California · Connecticut · Massachusetts · Michigan · New York · North Carolina · Oregon · Texas
NCT06953960 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
LMNA-Related Dilated Cardiomyopathy
Nuevocor Pte. Ltd. · started 2026-06-16
📍 Alabama · California · Massachusetts · Minnesota · Ohio · Texas
NCT07606274 on ClinicalTrials.gov ↗
Recruiting
Rheumatoid Arthritis
Surf Therapeutics · started 2026-03-20
📍 Texas
NCT07293871 on ClinicalTrials.gov ↗
Recruiting Phase 2
Obesity, Overweight, Diabetes Mellitus, Type 2
Eli Lilly and Company · started 2025-10-16
📍 Arizona · Florida · Georgia · Nevada · New Jersey · Ohio · Texas · Utah
NCT07215559 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Solid Tumors
Zai Lab (Shanghai) Co., Ltd. · started 2025-05-12
📍 California · Illinois · Michigan · New York · Ohio · Pennsylvania · Tennessee · Texas
NCT06885281 on ClinicalTrials.gov ↗
Starting soon Phase 1/Phase 2
Participants With Advanced Solid Tumor Malignancies
VelaVigo Bio Inc · started 2026-08-18
📍 Texas · Utah · Virginia
NCT07686068 on ClinicalTrials.gov ↗
Active Phase 2
Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome)
Tisento Therapeutics · started 2025-08-18
📍 California · Colorado · Georgia · Massachusetts · New York · Ohio · Pennsylvania · Texas
NCT06961344 on ClinicalTrials.gov ↗
Recruiting Phase 1
Hepatic Impairment
AstraZeneca · started 2026-03-20
📍 Arizona · California · Florida · Texas
NCT07546760 on ClinicalTrials.gov ↗
Active Phase 3
Primary Membranous Nephropathy
Hoffmann-La Roche · started 2021-06-25
📍 California · Colorado · Florida · Iowa · Michigan · Minnesota · New York · Texas
NCT04629248 on ClinicalTrials.gov ↗
Recruiting Phase 2
Type 1 Diabetes Mellitus
Mannkind Corporation · started 2026-02-04
📍 California · Colorado · Connecticut · Florida · Indiana · Massachusetts · Oklahoma · Texas
NCT07224321 on ClinicalTrials.gov ↗
Recruiting Phase 1
Advanced Metastatic Castration-resistant Prostate Cancer, Prostate Specific Membrane Antigen (PSMA) Expression
Bayer · started 2024-03-07
📍 California · Minnesota · Nebraska · Texas
NCT06217822 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Advanced Solid Malignancies
AstraZeneca · started 2022-06-24
📍 California · Illinois · Massachusetts · New York · Oregon · Texas · Virginia
NCT05417594 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Advanced Solid Tumors
CStone Pharmaceuticals · started 2025-02-24
📍 California · Texas
NCT06741644 on ClinicalTrials.gov ↗
Recruiting Phase 2
Colitis, Ulcerative
MRM Health NV · started 2026-04-03
📍 Florida · North Carolina · Texas
NCT07296315 on ClinicalTrials.gov ↗
Recruiting Phase 1
Healthy, Hepatic Impairment
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany · started 2025-05-07
📍 Florida · Texas
NCT06997276 on ClinicalTrials.gov ↗
Recruiting Phase 2
IgA Nephropathy
Jade Biosciences, Inc. · started 2026-05-19
📍 California · Colorado · Florida · Texas
NCT07541287 on ClinicalTrials.gov ↗
Active Phase 3
Rett Syndrome
Taysha Gene Therapies, Inc. · started 2023-03-06
📍 California · Illinois · Maryland · Massachusetts · Missouri · Texas
NCT05606614 on ClinicalTrials.gov ↗
Active Phase 1
Type 1 Interferonopathies
Boehringer Ingelheim · started 2025-07-29
📍 California · Pennsylvania · Texas
NCT06878365 on ClinicalTrials.gov ↗
Recruiting Phase 1
Advanced Malignant Solid Tumor, Solid Tumor Cancer
Pilatus Biosciences Inc · started 2026-02-13
📍 California · Texas
NCT07337525 on ClinicalTrials.gov ↗
Recruiting Phase 1/Phase 2
Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma (Skin), Renal Cell Carcinoma
AstraZeneca · started 2025-07-29
📍 Michigan · Missouri · Pennsylvania · Texas · Virginia
NCT07115043 on ClinicalTrials.gov ↗
No trials match your search.

Browse by state

California · 125 Florida · 104 Georgia · 66 Illinois · 58 Arizona · 57 Colorado · 55 Connecticut · 41 Michigan · 38 Indiana · 37 Alabama · 37 Massachusetts · 36 Texas · 35 New York · 32 Maryland · 27 Ohio · 24 Arkansas · 22

Browse by condition

Obesity · 7 Overweight · 6 Advanced Solid Tumors · 5 Neoplasm Metastasis · 4 Colitis, Ulcerative · 4 Melanoma · 3 Non-small Cell Lung Cancer · 3 Alzheimer Disease · 3 Crohn Disease · 3 Schizophrenia · 3 Small Lymphocytic Lymphoma · 2 Follicular Lymphoma · 2 Osteoarthritis · 2 Overweight or Obesity · 2 Alzheimers Disease · 2 Diabetes Mellitus, Type 1 · 2
Cite this page

Priya Life Science (2026). Clinical Trials in the USA Tracker. Available at: https://priyalifescience.com/clinical-trials-usa/state/texas (Accessed: 8 July 2026).

Source: ClinicalTrials.gov, U.S. National Library of Medicine — industry-sponsored studies in a recruiting status with at least one US site, most recently updated first, refreshed daily. This is a curated slice of the full registry, not every US trial. Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. Compare pay for the teams running these studies in our US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish and EU sites, see our Ireland and EU trackers.